This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

This study is currently recruiting participants.
See Contacts and Locations
Verified September 2017 by Emily Bellavance, University of Maryland
Sponsor:
Information provided by (Responsible Party):
Emily Bellavance, University of Maryland
ClinicalTrials.gov Identifier:
NCT02095184
First received: March 20, 2014
Last updated: September 1, 2017
Last verified: September 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2019
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)